Basic Information
The company's device monitors the heart, aiming to track significant changes in cardiac electrical signals, identify characteristics of acute thrombotic occlusion, and then alert patients to seek medical care immediately, enabling users to take action without any delay.
AngelMed
United States of America
15~50 people
January 01, 2001
relazioni.esterne@angelini.it

